🔗 Share this article

A shadow economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Investigational Drug Gaining Popularity Via Social Media

The experimental drug, which remains in research studies, is being promoted by online personalities for its alleged weight-reducing properties. Viewers are urged to message these accounts directly for source information, while also obtaining discount codes.

Thriving Commerce on Messaging Platforms

Separately, a robust trade exists on messaging services, where communities with thousands of participants share “before and after” photos, injection guides and claims of next-day UK delivery. Sellers market the substance there before directing buyers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Experts Voice Concerns

However, physicians and chemists have warned that the sale of what remains an unlicensed drug in the UK is a cause for concern and could lead to individuals injecting substances of unknown origin.

Some professionals stated the demand for retatrutide could be connected to the increasing cost of approved weight loss treatments such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still breach medicines, advertising, and customer laws, risking penalties, legal action or prison.

Service Response and Material Removal

Based on the social media company, the service has taken down violative content and prohibited related hashtags and search suggestions. The organization stated it was committed to keeping the platform safe and investing in strengthening enforcement strategies.

Digital Trading Activities

Research also found groups with up to 9,000 participants selling the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of users, populated with images of weight loss, positive reviews and detailed guides for mixing or injecting at residence.

After minutes of joining one group, a seller shared WhatsApp details, where the majority of transactions occur. The vendor sent an instruction manual and promised shipping within two days. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one asked about weight, medical conditions or previous experience.

Product Details and Pricing

Inside these groups, messages display black plastic parcels with Royal Mail stickers, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use pens typically sold at 160 pounds for 20mg. When asked how long a injector should be used, vendors give contradictory answers varying between a several days to “depends on your body”.

Service Oversight and Security Measures

A representative for Telegram stated it regularly moderated dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are administering substances they cannot confirm. Although the science behind this drug is valid, these online products may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service linked the increase in demand to current cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are using social media. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were made in was clean,” she said.

Her team has previously encountered individuals harmed by personal administration from unverified sources. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be impure or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company investigational substance not yet approved … may subject patients to potentially significant health risks”.